SCHEMBL3770259

SCHEMBL3770259

CNC(Cc1cccc(N)c1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.47
FOLH1 Q04609 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
MAOA P21397 2/20 0.43
MAOB P27338 2/20 0.43
MME P08473 1/20 0.42
ACE P12821 1/20 0.42
CPA1 P15085 1/20 0.42
ACE2 Q9BYF1 1/20 0.42
GRIA2 P42262 1/20 0.42
ADRB2 P07550 4/20 0.42
CPN1 P15169 1/20 0.42
CPB2 Q96IY4 1/20 0.42
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3770263 1.00 SLC7A5 (0.47) SLC7A5FOLH1L3MBTL1MAOAMAOB
SCHEMBL7999719 0.88 ADRB2 (0.45) SLC7A5MAOAMAOBGRIA2ADRB2
SCHEMBL6774452 0.85 GNPAT (0.51) FOLH1L3MBTL1MMEACECPA1
SCHEMBL6774455 0.85 GNPAT (0.51) FOLH1L3MBTL1MMEACECPA1
SCHEMBL31369667 0.85 MAOA (0.49) SLC7A5MAOAMAOBMMEACE
SCHEMBL2779453 0.85 GNPAT (0.51) FOLH1L3MBTL1MMEACECPA1
SCHEMBL25357295 0.84 SLC7A5 (0.47) SLC7A5FOLH1L3MBTL1MMEACE
SCHEMBL25357296 0.84 SLC7A5 (0.47) SLC7A5FOLH1L3MBTL1MMEACE
SCHEMBL25356427 0.83 CTSB (0.51) SLC7A5FOLH1L3MBTL1MMEACE
SCHEMBL25356432 0.83 CTSB (0.51) SLC7A5FOLH1L3MBTL1MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US claimed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed
CN-110087668-A The regulator of complement activity RA制药公司 2019-08-02 CN disclosed
CN-108697759-A modulators of complement activity RA制药公司 2018-10-23 CN disclosed
US-8569313-B2 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) 2013-10-29 US disclosed
US-20100305090-A1 META-SUBSTITUTED PHENYL SULFONYL AMIDES OF SECONDARY AMINO ACID AMIDES, THE PRODUCTION THEREOF, AND USE THEREOF AS MATRIPTASE INHIBITORS THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) 2010-12-02 US disclosed
CN-101466408-A Polycation-polyanion complexes, compositions, and methods of use thereof AERIS THERAPEUTICS INC (US) 2009-06-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305090-A1 META-SUBSTITUTED PHENYL SULFONYL AMIDES OF SECONDARY AMINO ACID AMIDES, THE PRODUCTION THEREOF, AND USE THEREOF AS MATRIPTASE INHIBITORS MMP7, DNPEP, METAP1 SLC7A5 95/4885FOLH1 215/4885L3MBTL1 2328/4885
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP SLC7A5 21/4885FOLH1 145/4885L3MBTL1 1836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.